1 / 8

Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027

The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027.<br>

Robert105
Download Presentation

Peptide Therapeutics Market Overview, Business Opportunities future, growth 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Peptide TherapeuticsMarket Analysis, Growth, Share, Market Trends 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Generic and Innovative), Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, and Others), Synthesis Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), and Hybrid Technology), and Application (Cancer, Cardiovascular Disorder, Metabolic Disorder, Respiratory Disorder, Pain, and Dermatology), and Geography

  3. Email:sales@theinsightpartners.com Peptide Therapeutics Market Overview • The Peptide Therapeutics Marketwas valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027. • The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth.

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Type (Innovative, Genericand Others) • Application (Cancer, Metabolic Disorder, Cardiovascular Disorder, Respiratory Disorder, Pain, Dermatology) • By Technology (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Technology) Download Sample

  5. Email:sales@theinsightpartners.com Peptide Therapeutics Market Value CAGR of 9.2% (2020 - 2027) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Eli Lilly and Company • Amgen Inc. • TEVA PHARMACEUTICAL INDUSTRIES LTD • Polypeptide Group • EVER Pharma GmbH • Bristol-Myers Squibb Company • Novo Nordisk A/S • Sanofi • AstraZeneca PLC • Glaxosmithkline PLC Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related